128 results
8-K
EX-99.1
PHIO
Phio Pharmaceuticals Corp
2 Apr 24
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
7:30am
statements regarding the anticipated benefits of our INTASYL™ RNAi platform and the results from our ongoing clinical trials, are based only on our
424B3
ws9jv44u n3t47q
28 Dec 23
Prospectus supplement
9:13am
8-K
EX-10.1
u7nh9j08e03m0w2
26 Jul 23
Departure of Directors or Certain Officers
4:30pm
424B3
7lg2poj cx5h1
20 Jun 23
Prospectus supplement
9:30am
8-K
EX-10.1
hcsr5qwuz0 m81xy
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.2
s0ub17sgh1jnispxs
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
424B5
6nsq175lgc0mnkw0e
1 Jun 23
Prospectus supplement for primary offering
5:00pm
424B3
m3ugnfs
10 May 23
Prospectus supplement
4:30pm